Prenetics Ltd Financials
Prenetics Ltd (PRE) reported $92.4M in revenue for fiscal year 2025, up 201.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Prenetics’ visible operating pattern today is rapid revenue scaling still financed by equity-supported cash burn, not by internally generated cash.
Revenue scaled sharply, and net margin improved to-43.3% from-162.7% , showing losses are shrinking faster as sales rise, but not yet enough to create positive cash generation. But cash burn still came from operations, not reinvestment: operating cash flow was-$21.8M and free cash flow-$22.0M , so the outflow reflects an unprofitable core more than a capital-heavy buildout.
Leverage is minimal—long-term debt was only
Cash fell from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Prenetics Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Prenetics Ltd, and counted as zero in the overall score.
Prenetics Ltd passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Prenetics Ltd reported a net loss of $40.0M while operations used $21.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Prenetics Ltd generated $92.4M in revenue in fiscal year 2025. This represents an increase of 201.7% from the prior year.
Prenetics Ltd reported -$40.0M in net income in fiscal year 2025. This represents an increase of 19.7% from the prior year.
Prenetics Ltd earned -$2.46 per diluted share (EPS) in fiscal year 2025. This represents an increase of 33.7% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Prenetics Ltd recorded an outflow of $22.0M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 26.3% from the prior year.
Prenetics Ltd held $32.1M in cash against $437K in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Prenetics Ltd's net profit margin was -43.3% in fiscal year 2025, showing the share of revenue converted to profit. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Prenetics Ltd's ROE was -25.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.5 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
Prenetics Ltd spent $639K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
Prenetics Ltd invested $208K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 79.3% from the prior year.
Not reported for fiscal year 2025.
PRE Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Revenue | $92.4M+201.7% | $30.6M+40.8% | $21.7M+65.2% | $13.2M+5.0% | $12.5M-80.8% | $65.2M |
| Interest Expense | $241K+18.7% | $203K-16.1% | $242K-0.8% | $244K+18.5% | $206K+316.8% | $49K |
| Income Tax | $34K+100.4% | -$7.9M-2827.1% | -$269K-9.8% | -$245K-109.5% | $2.6M+232.6% | -$1.9M |
| Net Income | -$40.0M+19.7% | -$49.8M+23.1% | -$64.8M+66.0% | -$190.5M-9.4% | -$174.0M-8760.8% | -$2.0M |
| EPS (Diluted) | -$2.46+33.7% | -$3.71+23.2% | -$4.83 | -$44.50 | -$225.17 | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income.
PRE Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Total Assets | $206.1M-3.5% | $213.6M-16.0% | $254.2M-18.6% | $312.1M+110.2% | $148.5M | N/A |
| Current Assets | $85.2M-1.1% | $86.1M-8.0% | $93.7M-61.3% | $241.8M+126.2% | $106.9M | N/A |
| Cash & Equivalents | $32.1M-38.5% | $52.3M+14.3% | $45.7M-68.8% | $146.7M+315.6% | $35.3M+143.5% | $14.5M |
| Inventory | $7.0M+7.1% | $6.6M+110.0% | $3.1M-31.0% | $4.5M-33.6% | $6.8M | N/A |
| Accounts Receivable | $14.8M-11.5% | $16.8M-5.0% | $17.7M-66.8% | $53.2M-3.1% | $54.9M | N/A |
| Goodwill | $1.4M-96.3% | $37.4M+28.1% | $29.2M-13.7% | $33.8M+749.7% | $4.0M-0.4% | $4.0M |
| Total Liabilities | $49.7M+17.7% | $42.2M-4.1% | $44.0M-35.9% | $68.7M-87.5% | $549.4M | N/A |
| Current Liabilities | $28.7M-21.4% | $36.6M-7.4% | $39.5M-31.0% | $57.2M-2.6% | $58.7M | N/A |
| Long-Term Debt | $437K-85.5% | $3.0M+247.6% | $867K-77.0% | $3.8M+4.5% | $3.6M | N/A |
| Total Equity | $156.4M-8.7% | $171.3M-18.5% | $210.2M-13.7% | $243.5M+160.7% | -$400.9M-1392.9% | $31.0M |
Not reported in any period shown, so not listed: Retained Earnings.
PRE Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -$21.8M+24.4% | -$28.9M-109.8% | -$13.8M-194.8% | $14.5M+8.2% | $13.4M+565.9% | -$2.9M |
| Capital Expenditures | $208K-79.3% | $1.0M+191.6% | $345K-93.0% | $4.9M-42.1% | $8.5M+198.5% | $2.9M |
| Free Cash Flow | -$22.0M+26.3% | -$29.9M-111.8% | -$14.1M-247.5% | $9.6M+96.5% | $4.9M+184.8% | -$5.7M |
| Investing Cash Flow | -$35.7M-192.6% | $38.5M+146.5% | -$83.0M-79.8% | -$46.1M-109.5% | -$22.0M-268.6% | -$6.0M |
| Financing Cash Flow | $37.5M+1220.8% | -$3.3M+28.9% | -$4.7M-103.3% | $143.3M+388.9% | $29.3M+147.5% | $11.8M |
| Share Buybacks | $639K | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
PRE Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Net Margin | -43.3% | -162.7% | -297.9% | -1446.8% | -1388.5% | -3.0% |
| Return on Equity | -25.6%+3.5pp | -29.1%+1.7pp | -30.8%+47.4pp | -78.2% | N/A | -6.3% |
| Return on Assets | -19.4%+3.9pp | -23.3%+2.2pp | -25.5%+35.5pp | -61.0%+56.2pp | -117.2% | N/A |
| Current Ratio | 2.97+0.6x | 2.360.0x | 2.37-1.9x | 4.23+2.4x | 1.82 | N/A |
| Debt-to-Equity | 0.000.0x | 0.020.0x | 0.000.0x | 0.02 | N/A | N/A |
| FCF Margin | -23.8%+73.7pp | -97.6%-32.7pp | -64.9%-137.6pp | 72.7%+33.8pp | 38.9%+47.7pp | -8.8% |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Where Prenetics Ltd Ranks
Frequently Asked Questions
What is Prenetics Ltd's annual revenue?
Prenetics Ltd (PRE) reported $92.4M in total revenue for fiscal year 2025. This represents a 201.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Prenetics Ltd's revenue growing?
Prenetics Ltd (PRE) revenue grew by 201.7% year-over-year, from $30.6M to $92.4M in fiscal year 2025.
Is Prenetics Ltd profitable?
No, Prenetics Ltd (PRE) reported a net income of -$40.0M in fiscal year 2025, with a net profit margin of -43.3%.
How much debt does Prenetics Ltd have?
As of fiscal year 2025, Prenetics Ltd (PRE) had $32.1M in cash and equivalents against $437K in long-term debt.
What is Prenetics Ltd's net profit margin?
Prenetics Ltd (PRE) had a net profit margin of -43.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Prenetics Ltd's return on equity (ROE)?
Prenetics Ltd (PRE) has a return on equity of -25.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Prenetics Ltd's free cash flow?
Prenetics Ltd (PRE) recorded an outflow of $22.0M in free cash flow during fiscal year 2025. This represents a 26.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Prenetics Ltd's operating cash flow?
Prenetics Ltd (PRE) recorded an outflow of $21.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Prenetics Ltd's total assets?
Prenetics Ltd (PRE) had $206.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Prenetics Ltd's capital expenditures?
Prenetics Ltd (PRE) invested $208K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Prenetics Ltd's current ratio?
Prenetics Ltd (PRE) had a current ratio of 2.97 as of fiscal year 2025, which is generally considered healthy.
What is Prenetics Ltd's debt-to-equity ratio?
Prenetics Ltd (PRE) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Prenetics Ltd's return on assets (ROA)?
Prenetics Ltd (PRE) had a return on assets of -19.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Prenetics Ltd's cash runway?
Based on fiscal year 2025 data, Prenetics Ltd (PRE) had $32.1M in cash against an annual operating cash burn of $21.8M. This gives an estimated cash runway of approximately 18 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Prenetics Ltd's Piotroski F-Score?
Prenetics Ltd (PRE) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Prenetics Ltd's earnings high quality?
Prenetics Ltd (PRE) reported a net loss of $40.0M while operations used $21.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Prenetics Ltd?
Prenetics Ltd (PRE) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.